%0 Journal Article
%T Hepatopulmonary syndrome after radiofrequency ablation of recurrent intrahepatic cholangiocarcinoma: a case report
%A Ai Zhong
%A Jian Chen
%A Kuansheng Ma
%A Qing Xiong
%A Yu Wang
%J Archive of "OncoTargets and therapy".
%D 2019
%R 10.2147/OTT.S86702
%X Radiofrequency ablation (RFA) is one of the definitive treatment modalities for liver cancer and has been increasingly used in the scenario of small-sized liver cancer. It is generally believed that RFA is minimally invasive and associated with a favorable safety profile in liver cancer patients. However, this interventional technique is subject to some morbidity in high-risk patients, such as those with complicating cirrhosis or a liver cancer located at a refractory segment
%K liver cancer
%K radiofrequency ablation
%K acute liver failure
%K hepatorenal syndrome
%K intensive care
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452817/